These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7294567)

  • 21. Antibiotic sensitivity and synergism of 'penicillin-tolerant' Staphylococcus aureus.
    Rozenberg-Arska M; Fabius GT; Beens-Dekkers MA; Duursma SA; Sabath LD; Verhoef J
    Chemotherapy; 1979; 25(6):352-5. PubMed ID: 260698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial susceptibility of Staphylococcus epidermidis and Staph. aureus.
    Davies AJ; Dyas A
    J Antimicrob Chemother; 1985 Jan; 15(1):127-8. PubMed ID: 3972755
    [No Abstract]   [Full Text] [Related]  

  • 23. Testing Staphylococcus aureus for resistance to beta-lactams.
    Goldstein FW; Acar J
    J Antimicrob Chemother; 1991 Apr; 27(4):549-50. PubMed ID: 1953884
    [No Abstract]   [Full Text] [Related]  

  • 24. Detection of glycopeptide resistance in Staphylococcus aureus.
    Walsh TR; Howe RA; Wootton M; Bennett PM; MacGowan AP
    J Antimicrob Chemother; 2001 Mar; 47(3):357-8. PubMed ID: 11222571
    [No Abstract]   [Full Text] [Related]  

  • 25. [Follow-up study of the antibiotic sensitivity and resistance of Staphylococcal strains cultured from osteomyelitis patients 1966-75 and 1976-80].
    Boda A; Hevér O; Mühsammer M
    Magy Traumatol Orthop Helyreallito Seb; 1986; 29(3):215-21. PubMed ID: 2874268
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro ceftriaxone susceptibility in methicillin-susceptible Staphylococcus aureus.
    Phe K; Dao D; Palmer HR; Tam VH
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1370. PubMed ID: 25403674
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of the 5 microg disc and the Neo-Sensitab for determining the susceptibilities of Staphylococcus aureus isolates to mupirocin.
    Finlay JE; Miller LA; Poupard JA
    J Antimicrob Chemother; 1998 Sep; 42(3):403-5. PubMed ID: 9786487
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of the source of susceptibility-test agar on the in vitro activity of antibiotics against Staphylococcus aureus].
    Ito Y; Yoshida T; Fujita S; Matsubara F
    Rinsho Byori; 1989 Jan; 37(1):84-8. PubMed ID: 2724585
    [No Abstract]   [Full Text] [Related]  

  • 29. Simple method for measuring the antibiotic concentration required to kill adherent bacteria.
    Miyake Y; Fujiwara S; Usui T; Suginaka H
    Chemotherapy; 1992; 38(5):286-90. PubMed ID: 1286571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Characteristics of gentamicin-resistant strains of Staphylococcus aureus isolated from diagnostic specimens].
    Gołuszko P; Grabowska A; Gospodarek E; Bugalski R; Marciniak M
    Przegl Epidemiol; 1984; 38(4):435-40. PubMed ID: 6533685
    [No Abstract]   [Full Text] [Related]  

  • 31. [Resistance to antibiotics of Staphylococcus aureus isolated at 2 city obstetrical hospitals].
    Rimzha MI
    Antibiotiki; 1978 Oct; 23(10):905-6. PubMed ID: 152093
    [No Abstract]   [Full Text] [Related]  

  • 32. Reliability of Vancomycin Sensitivity Assays for Staphylococcus Aureus.
    Syed MA; Ashfaq N; Saleem A; Fatima B
    J Coll Physicians Surg Pak; 2017 Dec; 27(12):795. PubMed ID: 29185415
    [No Abstract]   [Full Text] [Related]  

  • 33. Antibiotic susceptibility of Staphylococcus aureus community acquired strains.
    Mutton KJ; Andrew JH
    Med J Aust; 1982 May; 1(11):459-61. PubMed ID: 7048038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alternative antimicrobial options against multiply resistant Staphylococcus aureus.
    Brink AJ; Huygens F; Van Rensburg AJ
    J Antimicrob Chemother; 1993 Jan; 31(1):180-2. PubMed ID: 8444667
    [No Abstract]   [Full Text] [Related]  

  • 35. Evidence for reduction in breakpoints used to determine vancomycin susceptibility in Staphylococcus aureus.
    Wootton M; Walsh TR; MacGowan AP
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3982-3. PubMed ID: 16127089
    [No Abstract]   [Full Text] [Related]  

  • 36. Twenty months of screening for glycopeptide-intermediate Staphylococcus aureus.
    Aucken HM; Warner M; Ganner M; Johnson AP; Richardson JF; Cookson BD; Livermore DM
    J Antimicrob Chemother; 2000 Oct; 46(4):639-40. PubMed ID: 11020266
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of exposure to mupirocin on the survival and recovery of sensitive Staphylococcus aureus strains.
    Barr JG; Hogg GM; Smyth ET
    Ulster Med J; 1988 Apr; 57(1):50-7. PubMed ID: 3138804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution of Staphylococcus aureus under vancomycin selective pressure: the role of the small-colony variant phenotype.
    Lenhard JR; von Eiff C; Hong IS; Holden PN; Bear MD; Suen A; Bulman ZP; Tsuji BT
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1347-51. PubMed ID: 25451045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro antibiotic sensitivity test of Staphylococcus aureus isolated from mastitic milk.
    Bakken G; Gudding R
    Nord Vet Med; 1978 Jan; 30(1):15-17. PubMed ID: 625448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of five antibiotics against methicillin and gentamicin resistant Staphylococcus aureus.
    Jamal F; Abd Aziz HB; Jais MR
    Malays J Pathol; 1985 Aug; 7():41-3. PubMed ID: 3855178
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.